Sergio García-Blas

Dr. Sergio García-Blas

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Journal of the American Medical Directors Association
Verified
Journal Article
Closed access
CBClara Bonanad
Clara Bonanad
SGSergio García-Blas
Sergio García-Blas
FTFrancisco Tarazona-Santabalbina
Francisco Tarazona-Santabalbina
JSJuan Sanchis
Juan Sanchis
VBVicente Bertomeu-Gonzalez
Vicente Bertomeu-Gonzalez
Alberto CorderoAlberto Cordero
Alberto Cordero

25 March 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ACAna Mompeon Campos
Ana Mompeon Campos
LOLuis Ortega-Paz
Luis Ortega-Paz
XVXavier Vidal-Gomez
Xavier Vidal-Gomez
Tiago CostaTiago Costa
Tiago Costa
DPDaniel Pérez-Cremades
Daniel Pérez-Cremades
CHCARLOS HERMENEGILDO
CARLOS HERMENEGILDO
Despite the promising value of miRNAs in the diagnostic and prognostic of cardiovascular disease (CVD), recent meta-analyses did not support their potential. Methodological variances in studies may interfere with miRNA profile and affect their results. This study determines if the blood starting material is a source of variance in miRNA profile by performing a paired comparison in plasma and serum of the expression of primary miRNAs associated with CVD. Circulating miRNA yield was similar in both plasma and serum, although a significant increase was observed in patients with Non-ST-elevation myocardial infarction (NSTEMI) compared to control volunteers. When normalized by the expression of miR-484, different patterns of miRNA expression between serum and plasma. Although NSTEMI modified the expression of miR-1 and miR-208 in both serum and plasma, plasma displayed a higher variance than serum (Levene’s test p < 0.01). For miR-133a and miR-26a, differences were only detected in serum (p = 0.0240), and conversely, miR-499a showed differences only in plasma of NSTEMI (p = 0.001). Interestingly, miR-21 showed an opposite pattern of expression, being increased in serum (2−ΔΔCt: 5.7, p = 0.0221) and decreased in plasma (2−ΔΔCt: 0.5, p = 0.0107). Plasma and serum exhibit different patterns of circulating miRNA expression in NSTEMI and suggest that results from studies with different starting material could not be comparable.

1 July 2020 in Revista Española de Cardiología (English Edition)
Verified
Journal Article
Closed access
Clara BonanadClara Bonanad
Clara Bonanad
SGSergio García-Blas
Sergio García-Blas
Francisco José Tarazona-SantabalbinaFrancisco José Tarazona-Santabalbina
Francisco José Tarazona-Santabalbina
PDPablo Díez-Villanueva
Pablo Díez-Villanueva
AAAna Ayesta
Ana Ayesta
MVM. Vidán-Austiz
M. Vidán-Austiz

14 September 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SGSergio García-Blas
Sergio García-Blas
Alberto CorderoAlberto Cordero
Alberto Cordero
PDPablo Diez-Villanueva
Pablo Diez-Villanueva
MMMaria Martinez-Avial
Maria Martinez-Avial
AAAna Ayesta
Ana Ayesta
Clara BonanadClara Bonanad
Clara Bonanad
Coronary artery disease is one of the leading causes of morbidity and mortality, and its prevalence increases with age. The growing number of older patients and their differential characteristics make its management a challenge in clinical practice. The aim of this review is to summarize the state-of-the-art in diagnosis and treatment of acute coronary syndromes in this subgroup of patients. This comprises peculiarities of ST-segment elevation myocardial infarction (STEMI) management, updated evidence of non-STEMI therapeutic strategies, individualization of antiplatelet treatment (weighting ischemic and hemorrhagic risks), as well as assessment of geriatric conditions and ethical issues in decision making.

Verified
Journal Article
Open access
PDF file
CBCarlos Bea
Carlos Bea
SVSara Vela-Bernal
Sara Vela-Bernal
SGSergio García-Blas
Sergio García-Blas
JPJose-Angel Perez-Rivera
Jose-Angel Perez-Rivera
PDPablo Diez-Villanueva
Pablo Diez-Villanueva
Clara BonanadClara Bonanad
Clara Bonanad
The specific management of infective endocarditis (IE) in elderly patients is not specifically addressed in recent guidelines despite its increasing incidence and high mortality in this population. The term “elderly” corresponds to different ages in the literature, but it is defined by considerable comorbidity and heterogeneity. Cancer incidence, specifically colorectal cancer, is increased in older patients with IE and impacts its outcome. Diagnosis of IE in elderly patients is challenging due to the atypical presentation of the disease and the lower performance of imaging studies. Enterococcal etiology is more frequent than in younger patients. Antibiotic treatment should prioritize diminishing adverse effects and drug interactions while maintaining the best efficacy, as surgical treatment is less commonly performed in this population due to the high surgical risk. The global assessment of elderly patients with IE, with particular attention to frailty and geriatric profiles, should be performed by multidisciplinary teams to improve disease management in this population.

25 July 2018 in Biomarkers in Medicine
Verified
Journal Article
Closed access
JGJessika González-D’gRegorio
Jessika González-D’gRegorio
GMGema Miñana
Gema Miñana
JNJulio Núñez
Julio Núñez
ENEduardo Núñez
Eduardo Núñez
VRVicente Ruiz
Vicente Ruiz
JSJuan Sanchis
Juan Sanchis
Aim: We evaluated the relationship between iron deficiency (ID) and long-term mortality risk in elderly patients with acute coronary syndrome (ACS). Methods: In this prospective observational study, we included 252 patients older than 65 years with ACS. Transferrin saturation (TSAT) and ferritin were collected before discharge. Results: Mean age, hemoglobin and GRACE score were 78 ± 7 years, 12.4 ± 1.8 g/dl and 138.8 ± 25.3, respectively, 112(44.4%) patients were women, and 151(59.9%) presented ID. During the follow-up, 121 (48%) patients died. Mortality rates among TSAT quartiles were: 2.38, 1.60, 0.90 and 0.95 × 10 person-years for Q1TSAT to Q4TSAT, respectively (p < 0.001) and did not differ across ferritin quartiles (p = 0.601), whereas ID definition was borderline associated (p = 0.060). Adjusted TSAT levels remained inverse, nonlinearly associated with long-term mortality risk (p < 0.001), with an exponential increased-risk from values about 20% and below. Conclusion: Lower TSAT levels were independ...